ESensor Warfarin Sensitivity Saliva Test

Cytochrome P450 2c9 (cyp450 2c9) Drug Metabolizing Enzyme Genotyping System

GENMARK DIAGNOSTICS, INCORPORATED

The following data is part of a premarket notification filed by Genmark Diagnostics, Incorporated with the FDA for Esensor Warfarin Sensitivity Saliva Test.

Pre-market Notification Details

Device IDK152612
510k NumberK152612
Device Name:ESensor Warfarin Sensitivity Saliva Test
ClassificationCytochrome P450 2c9 (cyp450 2c9) Drug Metabolizing Enzyme Genotyping System
Applicant GENMARK DIAGNOSTICS, INCORPORATED 5964 LA PLACE COURT Carlsbad,  CA  92008
ContactAlan Maderazo
CorrespondentAlan Maderazo
GENMARK DIAGNOSTICS, INCORPORATED 5964 LA PLACE COURT Carlsbad,  CA  92008
Product CodeODW  
Subsequent Product CodeNSU
Subsequent Product CodeODV
CFR Regulation Number862.3360 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received2015-09-14
Decision Date2016-05-26
Summary:summary

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.